Clinical Trials Logo

Glucose Intolerance clinical trials

View clinical trials related to Glucose Intolerance.

Filter by:

NCT ID: NCT02938091 Completed - Dyslipidemia Clinical Trials

Dietary Modulation of Hepatic Lipase (LIPC) -514 C/T Variant Associations With Lipids and Glucose

Start date: January 2008
Phase: N/A
Study type: Interventional

The investigators evaluated dietary modulation of LIPC rs1800588 (-514 C/T) for lipids and glucose using a randomized cross-over design comparing a high-fat Western diet and a low-fat traditional Hispanic diet in Caribbean Hispanics (n=42; 4 weeks/phase).

NCT ID: NCT02934425 Completed - Pre-diabetes Clinical Trials

Effects of Lean Pork, High Protein Breakfast on Satiety and Metabolic Health in Pre-diabetes

Start date: August 2016
Phase: N/A
Study type: Interventional

The goal of this study is to assess the effects of consumption of a lean pork-containing, high-protein breakfast versus a refined carbohydrate-rich breakfast on satiety and cardiometabolic parameters in overweight or obese adults with pre-diabetes.

NCT ID: NCT02933424 Completed - Obesity Clinical Trials

Project Plant Protein: the P3 Study in Humans

Start date: September 2016
Phase: N/A
Study type: Interventional

The objective of this study is to compare the effects of adding three plant-based proteins (rice, oats and pea proteins) to a breakfast beverage on the glycemic response, appetite and subsequent food intake of healthy adults.

NCT ID: NCT02919397 Completed - Pre-diabetes Clinical Trials

Motivational Instant Messaging and E-diabetes Prevention Programme for High Risk of Type 2 Diabetes

Start date: October 1, 2016
Phase: N/A
Study type: Interventional

The overall aim of this feasibility trial is to assess the effectiveness of a wearable technology and an e-diabetes prevention programme delivered via a smartphone application, including motivational messaging, in reducing weight and increasing physical activity in people at risk of developing type 2 diabetes.

NCT ID: NCT02907190 Completed - Clinical trials for Impaired Glucose Tolerance

Glycemic and Insulinemic Impact of Selected Canadian Beans

MED-beans
Start date: March 2016
Phase: N/A
Study type: Interventional

The objective of this study is to compare the glycemic and insulinemic response elicited by ½ cup servings of 6 beans to those elicited by ½ cup servings of mashed potato, macaroni, rice and corn.

NCT ID: NCT02896010 Completed - Prediabetes Clinical Trials

Personalized Smartphone-assisted Coaching System to Improve Glucose Homeostasis in Adults With Prediabetes

Start date: October 10, 2016
Phase: N/A
Study type: Interventional

Sweetch is a personalized mobile-health platform coaching system (mobile phone app) designed to promote adherence to physical activity guidelines for people with prediabetes.

NCT ID: NCT02869659 Completed - Obesity Clinical Trials

Valued EpiGenetic Glycemic ImprovEments Through Weight Loss

VEGGIE
Start date: November 1, 2016
Phase: N/A
Study type: Interventional

This randomized controlled clinical trial will use methylomic and transcriptomic profiling to examine the effects of a weight loss intervention on the cholesterol metabolism gene network in monocytes and adipocytes and investigate the longitudinal relationship between these modifications and glycemic improvements.

NCT ID: NCT02868177 Completed - Obesity Clinical Trials

Effect of Totum-63, Active Ingredient of Valedia, on Glucose and Lipid Homeostasis on Subjects With Prediabetes

TOTUM-63 TWO
Start date: October 2016
Phase: Phase 2/Phase 3
Study type: Interventional

Given the data on the active ingredients of Totum-63, this research aims to evaluate the effect of its chronic consumption (24 weeks) on glucose and lipid homeostasis and especially on fasting plasma glucose in volunteers with abdominal obesity associated with impaired glucose tolerance or untreated type 2 diabetes and hypertriglyceridemia. This clinical study is designed to estimate the effect of Totum-63, active ingredient of Valedia, on several glucose and lipid homeostasis related parameters since these data are still unknown for this specific dietary supplement formula. Collected data will provide more reliable information which may be used to plan a subsequent larger main study.

NCT ID: NCT02866539 Completed - Diabetes Mellitus Clinical Trials

Effect of Polyherbal Compound for Control of Blood Sugar in Impaired Glucose Tolerance and Diabetes

Start date: December 2016
Phase: N/A
Study type: Interventional

The aim of the study is to control blood sugar with Sugar Balance capsules which is the leaves of three herbs: ivy ground (Coccinia indica)-200mg, bougainvillia (Bougainvillea spectabilis)-30mg, Madagascar periwinkle (Catharanthus rosea)-20mg.

NCT ID: NCT02848053 Not yet recruiting - Clinical trials for Type 2 Diabetes Mellitus

The Long-term Effect of Tianqi Capsule Interventions to Prevent Diabetes in the REDUCES Study: a 8-year Follow-up Study

Start date: August 2016
Phase: N/A
Study type: Observational

Objectives: This study is aimed to assess whether Tianqi Capsule interventions have a long-term effect on the risk of diabetes and provide evidence that early intervention by traditional Chinese medicine could delay the progression from impaired glucose tolerance to diabetes. Study contents: 1.420 participants were followed up for 8 years to assess the long-term effect of Tianqi Capsule. Phone-call followed up was applied to investigate the status of impaired glucose tolerance and orthoglycemic survivors until the end of REDUCES study. 2.To participants that determined the status of glucose metabolism, a variety of ways were used to find the evidence of diagnosis of glucose metabolic status, such as glycemia laboratory sheets from normal hospitals, medical records, the use of antidiabetic drugs or insulin injection, etc. 3. To participants that undiagnosed the status of glucose metabolism, oral glucose tolerance test, blood pressure, weight and blood biochemical analysis were performed to assess the state of glucose metabolism. 4. Questionnaires were given to all the participants to investigate their condition of treatment, diet, exercise and other lifestyle.